Skip to main content
. 2017 Aug 2;2017(8):CD001324. doi: 10.1002/14651858.CD001324.pub5
Methods Women 'randomly allocated' to 2 groups. Method of randomisation not reported
Participants 283 women attending the gyn clinic in a general hospital, Zhejiang, China. Women had regular menstrual periods and a single act of unprotected intercourse within 120 h of attending the clinic
Interventions Mife 50 mg vs Mife 25 mg, single dose, orally
Outcomes Observed number of pregnancies, side effects and changes in menstrual pattern
Notes
  1. Post‐randomisation exclusions or loss to follow‐up not reported

  2. Observed pregnancy/expected pregnancy/total number of women: Mife 50 mg 1/14/147; Mife 25 mg 2/14/136

Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Mentioned randomisation but description not adequate
Allocation concealment (selection bias) Unclear risk Method of allocation concealment not mentioned
Blinding (performance bias and detection bias) All outcomes Unclear risk Not mentioned
Incomplete outcome data (attrition bias) All outcomes Unclear risk Post‐randomisation exclusions or loss to follow‐up not reported
Selective reporting (reporting bias) Low risk Reported planned outcomes
Other bias Low risk None detected